Professional Documents
Culture Documents
L16 Antibiotics - in - Oral - Maxillofacial - Surgery
L16 Antibiotics - in - Oral - Maxillofacial - Surgery
& MAXILLOFACIAL
SURGERY
DR.ANN MARY GEORGE
• Antimicrobials are the greatest contribution of
the 20th century to therapeutics.
• Quinolones
• Beta lactam antibiotics
• Aminoglycosides
• Macrolides
• Nitro- imidazoles
• Sulfonamides
• Oxazolidinones
• Glycopeptides
• Others
2.BASED ON MECHANISM OF
ACTION
• Inhibit cell wall synthesis
• Inhibit protein synthesis
• Interfere with DNA function
• Cause misreading of m-RNA code & affect
permeability
• Inhibit DNA Gyrase enzyme
• Interfere with intermediary metabolism
3. SPECTRUM OF ACTIVITY
• NARROW SPECTRUM:
PENCILLIN G
ERYTHROMYCIN
• BROAD SPECTRUM:
TETRACYCLINE
CHLORAMPHENICOL
4.BASED ON TYPE OF ORGANISM AGAINST
WHICH THE DRUG IS PRIMARILY ACTIVE
AGAINST:
• Anti bacterial
• Anti viral
• Anti fungal
5. TYPE OF ACTION
• Bacteriostatic: sulfonamides
tetracyclines ,
erythromycin.
• Bactericidal: penicillin ,
ciprofloxacin
cephalosporin.
6. SOURCE
• Patient factors
• Organism related consideration
• Drug factors
COMBINED USE OF
ANTIMICROBIALS
• To achieve synergism
• To reduce severity or incidence of adverse
affects
• To prevent emergence of resistance
• To broaden spectrum of anti microbial
action
PHARMACOLOGY
SULFONAMIDES
Ceftriaxone
Ceftazidime
• Spectrum of activity.
• Erythromycin is broad spectrum antibiotic active against many
gram-positive and gram-negative bacteria, mycoplasmas,
chlamydiae, treponemas, and rickettsiae.
Aerobic bacteria.
PREPARATIONS
CLARITHROMYCIN:
• active orally
DOSE RELATED TOXICITY
• Liver damage
• Kidney damage
• Phototoxicity
• Effect on teeth and bones
• Antianabolic effect
• Increased intracranial pressure
• Diabetes insipidus
• Vestibular toxicity
CHLORAMPHENICOL
• It is a lincosamide
antibiotic
• It penetrates to most
skeletal and soft tissues.
• Causes
Pseudomemberaneus
enterocollitis
superinfection due to
clostridium difficle.
VANCOMYCIN
• It is a glycopeptide
antibiotic
• Active against
resistant organisms
• Not well absorbed
orally .
• Inhibits bacterial cell
wall synthesis.
METRONIDAZOLE
• Anaerobic infections
• It inhibits DNA synthesis, regardless of the growth phase of the organism, and is rapidly
bactericidal.
• Spectrum of activity
• Aerobes.
Metronidazole is not active against most aerobic bacteria.
• Anaerobes
1. Metronidazole is very active and bactericidal against anaerobes, especially gram-negative
anaerobes, including Bacteroides fragilis, other Bacteroides spp., and Fusobacterium spp.
Clostridium spp., including C.perfringens and C.difficile are susceptible to
metronidazole
2. The activity of metronidazole against anaerobic gram-positive cocci is much more
variable with resistance in up to half of tested isolates
3. Strains of Actinomyces and Propionibacterium (e.g., P.acnes) are resistant
• Parasites.
• Metronidazole is very active against Entamoeba histolytica, Giardia lamblia, and
Tricahomonas vaginalis.
NEW DEVELOPMENTS
• Oxazolidinones group
• Very active against
gram +ve .
• Active against most of
the resistant
organisms.
• Clinical trials have
shown that drug is
well tolerated.
QUINUPRISTIN
• Wound contamination
• Age of patient
• Nature of underlying disease
• Presence of necrotic tissue and a decreased blood supply.
SPECIFIC APPLICATION OF
ANTIBIOTIC USE IN
ORAL AND MAXILLOFACIAL SURGERY
DENTOALVEOLAR SURGERY:
• Odontogenic pathogens.
• Actinomyces are another prominent pathogen in
chronic osteomyelitis.
• Recommended regimen:
• 1st choice:
PENCILLIN
AQUEOUS PEN-2 mu IV every 4th hrly
OXACILLIN- 1gm IV every 4th hrly
After 48-72 hrs, PEN V 500mg 4hrly + CLOX 250mg
4hrly orally for 2- 4 wks
• 2nd choice:
CLINDAMYCIN 300- 600mg 6 hrly po
• 3rd choice: CEFAZOLIN/ CEPHALEXIN 500mg 6 – 8 hrly.
• 4th choice:
ERYTHROMYCIN 2g 6 hrly iv then 500mg every 6 hrly orally.
• The dose & duration of AMA dependent on severity of infection &
response
FACTORS AFFECTING SELECTION
OF ANTIBIOTIC
ALLERGY/INTOLERANCE/ ADVERSE
DRUG REACTIONS
• The history of allergy obtained from the patient/ from the patient's
family
• The choice of clindamycin, metronidazole/ newer antibiotics should be
considered
• The newer B-lactam antibiotics, the monobactams and carbepenems,
have much less frequent cross sensitivity with the penicillin group.
IMMUNE SYSTEM COMPROMISE